Company Filing History:
Years Active: 2025
Title: Tirupathi Rao Alajangi: Innovator in Heterocyclic Compounds
Introduction
Tirupathi Rao Alajangi is a notable inventor based in Vizianagaram, India. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds that target specific enzyme activities.
Latest Patents
Alajangi holds a patent for "Heterocyclic PAD4 inhibitors." This patent involves substituted heterocyclic compounds of Formula (Ia), which are designed to inhibit the activity of the PAD4 enzyme. The disclosure outlines methods for preparing these compounds, pharmaceutical compositions that include them, and their potential use in treating diseases or disorders associated with PAD4 enzyme activity. He has 1 patent to his name.
Career Highlights
Tirupathi Rao Alajangi is currently employed at Bristol-Myers Squibb Company, a leading global biopharmaceutical company. His work focuses on innovative solutions in drug development, contributing to advancements in medical treatments.
Collaborations
Throughout his career, Alajangi has collaborated with esteemed colleagues, including Kumaravel Selvakumar and Venkatram Reddy Paidi. These collaborations have fostered a productive environment for research and innovation.
Conclusion
Tirupathi Rao Alajangi is a distinguished inventor whose work in heterocyclic compounds has the potential to impact the treatment of diseases linked to PAD4 enzyme activity. His contributions to the pharmaceutical industry exemplify the importance of innovation in healthcare.